Investigators at the Securities and Exchange Commission have notified Martha Stewart that they plan to recommend civil securities fraud charges against her in connection with her sale of Imclone Systems Inc. shares, the Wall Street Journal reported.
Sec staff recommends civil charges against Martha Stewart.